Ultralife FY 2021: revenue $98.3M, down 9%; diluted EPS −$0.01

Key figures from this report

These are the numbers Ultralife reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$98.3M−9% from $107.7M in FY 202010-K income statement, on EDGAR
2. Net income−$234K−104% from $5.2M in FY 202010-K income statement, on EDGAR
3. Diluted EPS−$0.01−100% from $33.00 in FY 202010-K income statement, on EDGAR
4. Cash and cash equivalents$8.3M−21% from $10.6M in FY 202010-K balance sheet, on EDGAR
5. Cash from operations$4.3M−80% from $21.7M in FY 202010-K cash flow statement, on EDGAR

Every year in the financial tables